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Abstract
Background: Vitamin B12 is indispensable for proper brain functioning and cytosolic synthesis of S-adenosylmethionine.
Whether its deficiency produces effects on viability and apoptosis of neurons remains unknown. There is a particular interest
in investigating these effects in Parkinson disease where Levodopa treatment is known to increase the consumption of S-
adenosylmethionine. To cause deprivation of vitamin B12, we have recently developed a cell model that produces
decreased synthesis of S-adenosylmethionine by anchoring transcobalamin (TCII) to the reticulum through its fusion with
Oleosin (OLEO).
Methodology: Gene constructs including transcobalamin-oleosin (TCII-OLEO) and control constructs, green fluorescent
protein-transcobalamin-oleosin (GFP-TCII-OLEO), oleosin-transcobalamin (OLEO-TCII), TCII and OLEO were used for
expression in N1E-115 cells (mouse neuroblastoma) and in substantia nigra of adult rats, using a targeted transfection
with a Neurotensin polyplex system. We studied the viability and the apoptosis in the transfected cells and targeted tissue.
The turning behavior was evaluated in the rats transfected with the different plasmids.
Principal Findings: The transfection of N1E-115 cells by the TCII-OLEO-expressing plasmid significantly affected cell viability
and increased immunoreactivity of cleaved Caspase-3. No change in propidium iodide uptake (used as a necrosis marker)
was observed. The transfected rats lost neurons immunoreactive to tyrosine hydroxylase. The expression of TCII-OLEO was
observed in cells immunoreactive to tyrosine hydroxylase of the substantia nigra, with a superimposed expression of
cleaved Caspase-3. These cellular and tissular effects were not observed with the control plasmids. Rats transfected with
TCII-OLEO expressing plasmid presented with a significantly higher number of turns, compared with those transfected with
the other plasmids.
Conclusions/Significance: In conclusion, the TCII-OLEO transfection was responsible for apoptosis in N1E-115 cells and rat
substantia nigra and for Parkinson-like phenotype. This suggests evaluating whether vitamin B12 deficit could aggravate the
PD in patients under Levodopa therapy by impairing S-adenosylmethionine synthesis in substantia nigra.
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Introduction
Vitamin B12 (cobalamin) deficiency in human has long been
linked to pernicious anemia. However, this is not the only ailment
caused by the lack of cobalamin. A neurological counterpart of this
anemia is the SCD, subacute combined degeneration [1]. Vitamin
B12 deficiency leads to memory disturbance, cognitive decline and
dementia [2]. With few exceptions, the pathological consequences
of vitamin B12 deficiency have been based on the only two known
vitamin B12 dependent biochemical reactions in the mammalian
cells, involving the mitochondrial L-methylmalonyl-coenzyme A
mutase (MMCM; EC 5.4.99.2) and the cytoplasm homocysteine
(Hcy) methyltransferase, also referred as methionine synthase (MS;
EC 2.1.1.13) [2]. Inferences made are thus based on the two direct
consequences of lacking B12: the accumulation of methylmalonic
acid and Hcy. Hcy is a metabolite of the essential amino acid
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methionine synthase, an enzyme that requires folate (vitamin B9)
and vitamin B12, or be catabolized by cystathionine beta-synthase
(CBS) to generate cysteine [3]. Methionine is converted into S-
adenosylmethionine (SAM), which is the universal methyl donor in
the trans-methylation reactions involved in epigenetic functions,
cell metabolism, and neurotransmitter synthesis and catabolism.
Despite the wealth of information available for the pathology of
cobalamin deficiency, it remains difficult to explain the molecular
mechanisms that can bring about all the neurological manifesta-
tions observed, since their identification is limited by the lack of
specific experimental cell and animal models [2]. In particular,
whether the vitamin B12 deficiency produces effects on viability
and apoptosis of dopaminergic neurons remains unknown. There
is a particular interest in investigating these effects in Parkinson
disease where Levodopa treatment is known to increase the
consumption of S-adenosylmethionine [4].
Several models of vitamin B12 deprivation have been developed
in vitro and in vivo to determine the biochemical and molecular
mechanisms of the cell impairment caused by vitamin B12
deficiency. The in vitro models consist of the use of culture media
lacking vitamin B12 or supplemented with Hcy [5–7]. The models
in experimental animals follow various designs and strategies. One
chronically provides diets without vitamin B12 and methyl donors
to pregnant rats and evaluates afterwards alterations in the pups of
the treated dams [8,9]. The other is to provide diets lacking
vitamins or supplemented with Hcy to adult animals [10,11]. The
neurological effects of the deficient diet has been documented in
one of these in vivo models [8]. The deficiency of dams in methyl
precursors, folate, vitamin B12 and choline contributes to an
impaired cognition, and at the tissue level to the apoptosis linked
with Hcy accumulation and atrophy of the CA1 hippocampus
atrophy in pups [8,12]. The deficiency in vitamin B12, folate and
vitamin B6 also produces a rarefaction of hippocampus micro-
vasculature in adult mice [13]. Gastrectomy in rats has been used
to abolish the secretion of intrinsic factor, the protein responsible
for the intestinal absorption of vitamin B12. Beside the B12
deficiency, this model produces dramatic effects related with a
central and peripheral neuropathy, concurrently with a denutri-
tion and a deficit in other important nutrients such as iron, folic
acid, and vitamin E [2,14,15].
To cause deprivation of vitamin B12, we have recently
developed a cell model deficient in B12 by anchoring transcoba-
lamin (TCII) to the endoplasmic reticulum through its fusion with
Oleosin (OLEO), a plant protein localized to lipid droplets and
endoplasmic reticulum of plant cells [16–18]. TCII is the
plasmatic transporter of vitamin B12 with high affinity and
specificity for B12 binding [18]. OLEO is a plant protein
anchoring onto the surface of seed oil bodies by its central
hydrophobic domain, which was used to target the secreted TCII
protein to the intracellular membranes of reticulum, in mamma-
lian cells [16–18]. These plasmids were transfected into various
cell lines, including N1E-115 neuroblastoma cells. TCII-OLEO
was a very efficient chelator of cobalamin while OLEO-TCII
transfected cells were no different from the either wild type non-
transfected cells or cells expressing TCII alone. This suggested that
integration of TCII in the C-terminal of the OLEO impaired the
B12 binding capacity of the chimer protein [16,19].
The use of anti-TCII antibodies produces vitamin B12 deficiency
and impairs the growth of leukemia cells by a mechanism related
with cell viability [20]. Whether B12 selective deficiency produces
effects on viability and apoptosis of brain tissue remain unknown,
probably because of experimental limitations. Indeed, studies in
CNS-related B12 deficit should consider not only the proliferated
state of neurons, but also the fully differentiated mature CNS, given
the dramatic neurological effects of B12 deficiency in the elderly
[2]. Cell models such as N1E-115 are tyrosine hydroxylase (TH)
expressing cells adapted for evaluating the effects of B12 in
proliferatingcells butnot thoseinmature CNSsinceonce these cells
reach fully differentiation state, they rapidly become detached from
the culture dishes, reflecting the cell death. To encompass this
problem, we therefore aimed to use our TCII-OLEO chimera
model for performing targeted in vivo transfection of the plasmid
constructs in the substantia nigra of adult rats and compared the
viability effects with those in N1E-115 cells. We studied the
functional consequences of the TCII-OLEO transfection in the
targeting tissue by comparing the behavior of the rats after
unilateral transfection with the different plasmid constructs.
Results
Transgenic Expression
The transgenic expression in N1E-115 cells was assessed by RT-
PCR, western blot, and immunofluorescence assays. RT-PCR
showed the expected amplified product of 1347 bp for TCII-
OLEO, 1240 bp for OLEO-TCII, 551 bp for TCII, and 275 bp
for OLEO (Fig. 1A). The recombinant chimera and TCII had the
expected size in western blotting with anti-TCII, while no TCII
protein was detected after the transfection with either the plasmid
pCMV-OLEO or the empty plasmid (Fig. 1B). The TCII-OLEO
transfected cells had a dramatically higher binding with labeled
B12 in the membrane fraction, compared with other transfected
cells, when
57Co-labeled Cobalamin was incorporated into culture
medium for three days (Fig. 1C). The expression of the
recombinant proteins was also evidenced by the indirect
immunofluorescence in the transfected N1E-115 cells, using an
anti-TCII polyclonal antibody (Fig. 1D).
Intracellular Location of the Protein Fusion TCII-OLEO
To show the functionality of OLEO as an anchoring protein to
immobilize TCII in cell membrane structures after their transgenic
expression, we made co-location assays of the expression of the
triple fusion protein GFP-TCII-OLEO by immunostaining of
either calreticulin, a protein of ER membrane, or golgin 97, a
protein of Golgi apparatus, as described previously in COS-7 cells
[16]. Confocal microscopy analysis showed that the fluorescence of
the triple fusion protein GFP-TCII-OLEO co-located with
calreticulin rather than with golgin 97 (Fig. 1E), suggesting the
anchoring of the chimeric protein mainly on ER membrane.
Cell Viability
We explore whether the expression of the anchoring chimeric
proteins in membrane structures would lead to cytotoxic effects
possibly associated with vitamin B12 deprivation. Viability assays
with MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
bromide) were made in murine neuroblastoma N1E-115 cells
stability transfected with each of the plasmids of interests. Only the
transfection of TCII-OLEO significantly affected the cell viability
when compared with the transfection of OLEO or TCII plasmids
(Fig. 2A). The statistical significance was between the sixth and
seventh days of culture. Interestingly, cells transfected with
OLEO-TCII showed kinetics similar to that of the control cells,
suggesting that the expression of this fusion protein was not
cytotoxic.
Apoptosis and Necrosis in Stably Transfected Cells
To determine the type of cell-death in the stably transfected
cells, we used western blotting and immunofluorescence of cleaved
Vitamin B12 and Parkinson
PLoS ONE | www.plosone.org 2 December 2009 | Volume 4 | Issue 12 | e8268Figure 1. Expression of transcobalamin/oleosin chimeric proteins in transfected N1E-115 cells. A: Transgenic expression in N1E-115 cells
at 48 h after transfection using lipofectamine. The cells were transfected with one of the following plasmids: pCMV-TCII-OLEO coding for
transcobalamin-oleosin (lane 1), pCMV-OLEO-TCII coding for oleosin-transcobalamin (lane 2), pCMV-TCII coding for transcobalamin II (lane 3), pCMV-
OLEO coding for oleosin (lane 4), pCDNA3 (lane 5), and pCMV-GFP-TCII-OLEO coding for GFP-TCII-OLEO (lane 6). The housekeeping gene was b-actin.
The size in bp of the amplified products was 1347 for transcobalamin-oleosin (TCII-OLEO), 1240 for oleosin-transcobalamin (OLEO-TCII), 551 for
transcobalamin II (TCII), 275 for oleosin (OLEO), and 349 for b-actin. B: Western blotting of homogenate of N1E-115 cells transfected with the various
plasmids. From lane 1 to 6: homogenates from cells transfected with pCMV-TCII-OLEO, pCMV-OLEO-TCII, pCMV-TCII, pCMV-OLEO, empty plasmid,
pCMV-GFP-TCII-OLEO, respectively. C: Vitamin B12 binding capacity in transfected cells.
57Co-labeled Cobalamin (Cbl, ,300 mCi per mg) was
incorporated into culture medium (30,000 dpm/mL) for three days. The total amount of radioactivity taken by each cell lines was measured in pellets
and supernatants. Mean and S.E.M. are indicated. D: Indirect immunofluorescence of TCII in N1E-115 cells transiently transfected with lipofectamine.
The four constructs and the empty plasmid were tranfected in N1E-115 cells (1–5). The immunofluorescence was done with a goat polyclonal
antibody to TCII and a donkey antigoat IgG fluorescein labeled. Cell nuclei were counterstained with Hoechst 33258. Calibration bars=10 mm. E:
Confocal analysis showing co-localization of the protein GFP-TCII-OLEO with endoplasmic reticulum in transfected N1E-115 cells. The cells were
transfected with the plasmid pCMV-GFP-TCII-OLEO coding for GFP-transcobalamin-oleosin (GFP-TCII-OLEO), using lipofectamine. Cell nuclei were
counterstained with Hoechst 33258 (1, 5). Co-localization was evidenced with fluorescence from GFP (2, 6), immuno-fluorescence with a mouse
monoclonal antibody to the human golgin-97 (3) or a rabbit polyclonal antibody to calreticulin (7) and merge fluorescence (4,8). The secondary
antibodies include a donkey IgG anti-mouse TRITC labeled or a donkey IgG anti-rabbit TRITC labeled. Calibration bars=20 mm.
doi:10.1371/journal.pone.0008268.g001
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blotting against p53 as apoptosis markers (Fig. 2 and 3). The
uptake of propidium iodide uptake was used as a necrosis marker.
A significant increase in the immunoreactivity to both p53 and
cleaved Caspase-3 was observed after 5 days of culture in N1E-115
cells transfected with TCII-OLEO plasmid (Fig. 2 and 3), while no
change was observed in earlier growth delay (Fig. 2). The
immunoreactivity of cleaved Caspase-3 was much higher in
TCII-OLEO expressing cells than in cells transfected with the
other constructs (Fig. 2B and 3). No difference was observed in the
uptake of propidium iodide when compared with the control
values (Fig. 3), indicating that apoptosis was the main type of cell
death caused by the expression of TCII-OLEO protein.
Consistently with the viability assays, the transfection of OLEO-
TCII plasmid did not increase either cleaved Caspase-3 or
propidium iodide uptake (Fig. 2B and 3).
Transfection of the Plasmids in Rats
pCMV-GFP-TCII-OLEO, pCMV-TCII-OLEO, pCMV-OLEO-
TCII, pCMV-OLEO, pCMV-TCII, and pCDNA3 were transfected
in vivo into nigral neurons of adult rats, using the neurotensin (NTS)-
polyplex targeting system. The expression of TCII-OLEO and
OLEO-TCII were shown in homogenates of the substantia nigra 60
days after the transfection using RT-PCR (Fig. 4A). The expression
of GFP-TCII-OLEO in substantia nigra was observed 7 days after the
transfection (Fig. 4B). The immunodetection of TCII was observed
in TH-immunoreactive neurons of rats transfected with pCMV-
TCII-OLEO (Fig. 4C). The TCII-OLEO-transfected rats lost TH-
immunoreactive neurons (Fig. 5A). A weak effect was observed in
OLEO-TCII transfected animals, while the activity of rats
transfected with either the TCII or OLEO plasmids was similar
to that of the animals transfected with the empty plasmid pCDNA3
(Fig. 5A). Co-location of the immunoreactivities of TH and cleaved
Caspase-3 was evidenced in the substantia nigra of the TCII-OLEO-
transfected animals (Fig. 5B). In addition, the TH-immunoreactive
neurons expressing the cleaved Caspase-3 were also those
expressing the TCII-OLEO chimera (Fig. 5C).
Behavior and Methamphetamine-Induced Turning Test
in Transfected Rats
The rats transfected with pCMV-TCII-OLEO presented with a
significantly higher number of ipsilateral turns, compared with the
animals transfected with either the pCMV-OLEO-TCII, pCMV-
TCII pCMV-OLEO or the empty pCDNA3 plasmids (Fig. 6).
The number of ipsilateral turns reported in OLEO-TCII rats was
not statistically significant from that reported in the other control
groups. No difference among the different groups of transfected
rats was reported in the open field test (data not shown).
Discussion
The transgenic expression of TCII-OLEO, OLEO-TCII, TCII,
and OLEO in N1E-115 cells was ascertained by three complemen-
tary experiments, RT-PCR of mRNAs, western blot and confocal
immunofluorescence analysis of the protein products. In addition,
the fusion protein GFP-TCII-OLEO was anchored mainly in the
membrane of endoplasmic reticulum of the transfected N1E-115
cells, as previously showed for COS-7 cells [16]. This was supported
by the co-location of the fusion protein GFP-TCII-OLEO with the
immunostaining of calreticulin, a calcium pump in ER membrane,
and the absence of co-location with the immunostaining of golgin-
97, a marker Golgi apparatus [21,22]. We also confirmed that the
TCII-OLEO chimera produced a significant binding of vitamin B12
inthecellular membrane fraction ofthe transfected cells. In contrast,
the OLEO-TCII chimera produced the same vitamin B12 binding
as the TCII- and OLEO-transfected cells, as previously showed
[16,23]. N1E-115 cells expressing TC-OLEO, but not those
expressing OLEO-TC, have an impaired cellular metabolism of
Figure 2. Viability and apoptosis of N1E-115 cells stably transfected with different plasmids. The plasmids were pCMV-TCII-OLEO coding
for transcobalamin-oleosin (TCII-OLEO), pCMV-OLEO-TCII coding for oleosin-transcobalamin (OLEO-TCII), pCMV-TCII coding for transcobalamin II
(TCII), pCMV-OLEO coding for oleosin (OLEO), and pCDNA3. A: Cell viability and apoptosis among growth delay in proliferated state was monitored by
the absorbance of formazan dye resulting from enzymatic metabolism of MTT by the mitochondrial dehydrogenase. The no reagent blank was MTT
alone (0.5 mg/mL in culture medium). Western blot analysis of the temporal course of p53 in cells transfected with pCMV-TCII-OLEO was made by
using a mouse anti-p53 antibody and a mouse anti-actin antibody, which were revealed with a goat anti-mouse IgG coupled to peroxidase. Cleaved
Caspase-3 was identified by a rabbit anti-caspase-3 polyclonal antibody and a donkey anti-rabbit secondary antibody (labeled with peroxidase). B:
Western blotting of cleaved Caspase-3 at Day 7 of proliferate state. The mean6S.E.M. were obtained from three independent experiments made in
triplicate. Two-way ANOVA and Bonferoni post-test analyzed statistical differences from the control groups. *, P,0.05; **, P,0.01; ***, P,0.001.
doi:10.1371/journal.pone.0008268.g002
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acid. Compared with OLEO-TC expressing cells, the TC-OLEO
expressing cells had a decreased proliferation rate, an increased
expression of p38 and a decreased expression of ERK 1/2 [23]. This
may explain that, of the five plasmids individually assessed, only the
transfection of pCMV-TCII-OLEO caused apoptotic cell-death.
The increased immunoreactivity in cleaved Caspase-3, the active
form of this cysteine protease, and the absence of propidium iodide
uptake supported the presence of apoptosis and absence of necrosis
in the TCII-OLEO expressing cells. No differences in cell viability
and apoptosis were observed between the cells expressing OLEO-
TCII, TCII or OLEO, or transfected with the empty plasmid,
showing that the apoptotic effect was produced neither by OLEO
nor TCII. We showed recently that the stable transfection of N1E-
115 cells with the TCII-OLEO plasmid leads to decreased
conversion of cyano-cobalamin to methyl-cobalamin, the co-factor
of methionine synthase, and this is accompanied by a subsequent
decrease in the activity of methionine synthase and an increase of
Hcy and reduced SAM [16,23]. These effects on intracellular
metabolism are not observed in the cells transfected with the other
plasmids.
The in vivo transfection of rats with the TCII-OLEO expressing
plasmid produced similar effects as those observed with N1E-115
transfected cells, with the loss of neurons expressing TH and an
increased expression for cleaved Caspase-3 expression in the
substantia nigra. Taken together, our data strongly suggest that the
intracellular sequestration of vitamin B12 by the TCII-OLEO
protein anchored to ER might be the cause of the apoptotic cell-
death, by a mechanism related with vitamin B12 impaired
metabolism.
The nutritional in vivo models of global B12 deficiency are not
adapted for investigating the Parkinson-like phenotype. In these
models, the deficient diet would theorically produce bilateral
effects on substantia nigra, in addition to other effects on other
brain regions and to peripheral neuropathy, anemia and muscular
weakness [8–15]. These effects may complicate the interpretation
Figure 3. Analysis of apoptosis in N1E-115 cells stably transfected with different plasmids. The plasmids were pCMV-TCII-OLEO coding
for transcobalamin-oleosin (TCII-OLEO), pCMV-OLEO-TCII coding for oleosin-transcobalamin (OLEO-TCII), pCMV-TCII coding for transcobalamin II
(TCII), pCMV-OLEO coding for oleosin (OLEO), and pCDNA3. The immunofluorescence was done with a rabbit polyclonal antibody to cleaved Caspase-
3 and a donkey antirabbit IgG fluorescein labeled. Before fixation, cells were incubated with 4 mM propidium iodide for 10 min. Cell nuclei were
counterstained with Hoechst 33258. Calibration bars=100 mm.
doi:10.1371/journal.pone.0008268.g003
Vitamin B12 and Parkinson
PLoS ONE | www.plosone.org 5 December 2009 | Volume 4 | Issue 12 | e8268Figure 4. Expression of transcobalamin II/oleosin (TCII/OLEO) chimeric proteins in rats 60 days after transfection with the NTS-
polyplex.A:RT-PCRfromtheplasmidtranscriptsinthesubstantianigraofrats.Agroupofrats(n=3)wastransfectedwiththeplasmidpCMV-TCII-OLEO
and another (n=3) with the plasmid pCMV-OLEO-TCII. RT-PCR amplified a fragment of 380 bp for TCII-OLEO, a fragment of 394 for OLEO-TCII, and a
fragment of 349 for b-actin, the internal control. Lane 1 corresponds to the amplified fragment from the plasmid (positive control). Lane 2 is a PCR in the
absenceofplasmidorcDNA(negativecontrol).Theamplifiedproductfromthetransfectedsubstantianigraofeachratcorrespondstothelanes3,5,and
7, and the lanes 4, 6, and 8 show the RT-PCR outcome from the non-transfected side. B: GFP immunofluorescence in the rat substantia nigra transfected
with pCMV-GFP-TCII-OLEO. ThepCMV-GFP-TCII-OLEOencodesfor the fusionprotein green fluorescent protein-transcobalamin-oleosin (GFP-TCII-OLEO).
The immunofluorescence was done with a mouse monoclonal antibody to GFP and a donkey antimouse IgG fluorescein labeled. Representative
micrographs of coronal section of control substantia nigra (1) and transfected substantia nigra (2) of the same rat are presented. Calibration
bars=100 mm. C: Double immunofluorescence against TCII and tyrosine hydroxylase (TH) in the substantia nigra of rats. The neurons were transfected
with NTS-polyplex with pCMV-TCII-OLEO coding for transcobalamin-oleosin (TCII-OLEO). Slices from mesencephalon (40 mm) were immunostained at
7-day after transfection. The primary antibodies were a goat polyclonal anti-TCII and a mouse monoclonal anti-TH. The secondary antibodies were a
donkey antigoat IgG fluorescein labeled and a donkey antimouse IgG rhodamine labeled. Representative micrographs of coronal section of control
substantia nigra (1–3) and transfected substantia nigra (4–6) of the same rat are presented. Calibration bars=50 mm.
doi:10.1371/journal.pone.0008268.g004
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PLoS ONE | www.plosone.org 6 December 2009 | Volume 4 | Issue 12 | e8268Figure 5. Apoptosis of tyrosine hydroxylase (TH) immunoreactive cells in the substantia nigra of rats transfected with several
plasmids. A: TH-immunoreactive neurons after transfection. The neurons were transfected with NTS-polyplex with one of the following plasmids,
pCMV-TCII-OLEO coding for transcobalamin-oleosin (TCII-OLEO, 1), pCMV-OLEO-TCII coding for oleosin-transcobalamin (OLEO-TCII, 2), pCMV-TCII
coding for transcobalamin II (TCII, 3), pCMV-OLEO coding for oleosin (OLEO, 4), and the pCDNA3, the empty plasmid (5). Mesencephalon slices
(40 mm) were immunostained at 2-month after transfection with a mouse monoclonal antibody to TH and a donkey antimouse IgG fluorescein
labeled. Representative micrographs of sagital section of the rat mesencephalon are presented. Calibration bars=200 mm. B: Apoptosis in TH-
immunoreactive neurons after transfection with the plasmid pCMV-TCII-OLEO. Representative micrographs of the substantia nigra (with double
immunostaining at 15-day after transfection) are presented. The primary antibodies were a mouse monoclonal antibody to TH, and a rabbit
polyclonal antibody to cleaved Caspase-3. The secondary antibodies included a donkey anti-mouse IgG FITC labeled (1 and 4), and a donkey anti-
rabbit IgG rhodamine labeled (2 and 5). Representative micrographs of coronal section of control substantia nigra (1–3) and transfected substantia
nigra (4–6) of the same rat are presented. Scale bars=50 mm. C: Apoptosis in TH immunoreactive neurons expressing the TCII-OLEO chimera.
Representative micrographs of the substantia nigra with triple immunostaining at 15-day after transfection. The primary antibodies were a mouse
monoclonal antibody to TH, a goat polyclonal antibody to TCII, and a rabbit polyclonal antibody to cleaved Caspase-3. The secondary antibodies
were a donkey anti-mouse IgG AMCA labeled (1 and 5), a donkey antigoat IgG fluorescein labeled (2 and 6), a donkey anti-rabbit IgG rhodamine
labeled (3 and 7). Representative micrographs of coronal section of control substantia nigra (1–4) and transfected substantia nigra (5–8) of the same
rat are presented. Scale bars=50 mm.
doi:10.1371/journal.pone.0008268.g005
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contrast, our experimental approach allowed the evaluation of the
behavior consequences produced by the selective and unilateral
lesions of substantia nigra, where methamphetamine is expected to
stimulate only the intact non-transfected cells. Methamphetamine-
induced turning in rats transfected with several plasmids provided a
nice confirmation of the consequence of the loss of dopaminergic
neurons in the substantia nigra of the TCII-OLEO transfected rats.
The number of ipsilateral turns was 4.5-fold higher in TCII-OLEO
transfected animals, compared with those expressing the OLEO-
TCII chimera. The difference between the TCII-OLEO transfect-
ed rats and the other groups of transfected rats was only evidenced
after 60 days. This could be related with the time needed in vivo for
producing a B12 deficiency in transfected tissue, as a function of the
existing store of B12 in brain [8]. The turns were ipsilateral to the
side of the transfection, in consistence with the amphetamine
stimulation of the intact side of the substantia nigra [24].
Various effects of vitamin B12 deficiency may explain the
apoptotic effect observed in vitro and in vivo in lived transfected rats.
Apoptosis could be related with the TNF pathway as previous
observations made in humans deficient in B12 showed an
increased level TNF in the spinal fluid [2,25]. The decreased
activity of methionine synthase leads to an impaired re-
methylation and an accumulation of Hcy [16]. Accumulation of
Hcy and deficit in methyl groups produce apoptotic cell death, as
evidenced in several animal models and in vitro [6–9].
Plasma Hcy, vitamin B12 and folate and the C677T mutation
in MTHFR are associated with Parkinson disease (PD) [26–29].
Hyperhomocysteinemia has been linked to PD by oxidative effect
[30–33] and influences dopamine synthesis [34], while Levodopa
treatment promotes hyperhomocysteinemia [35–37]. The hyper-
homocysteinemia in Levodopa treated PD patients could be
related with the increased consumption of SAM in the O-
methylation of Levodopa, catalyzed by catechol-O-methyltrans-
ferase (COMT) [38]. Consequently, folate and vitamin B12
supplementations reduce the hyperhomocysteinemia in PD
patients on Levodopa therapy [35]. Our data suggest that the
deficiency in vitamin B12 could have dramatic effect on the
dopaminergic cells, in patients under Levodopa therapy, consid-
ering that (i) B12 deficiency decreases the cellular content in SAM,
as has been showed in B12 deficient N1E-115 cells (ii) Levodopa
enhances the cellular consumption of SAM, a metabolic condition
that may accentuate the apoptotic effect of B12. Given the relative
frequency of vitamin B12 deficiency in the elderly [39,40], our
data suggest a further evaluation of the cellular, tissular and
functional consequences of Levodopa in case of B12 deficiency,
using the TCII-OLEO cells and our model of transfected rat with
Parkinson-like phenotype.
In conclusion, the cellular impaired metabolism of vitamin
produced by TCII-OLEO transfection is responsible for apoptosis
in N1E-115 cells and in rats and for Parkinson-like phenotype in
the transfected rats. This suggests evaluating the consequences of
vitamin B12 deficit in PD patients under Levodopa therapy.
Methods
Plasmids
Three plasmids coding for the fusion protein between the
human TCII and the plant OLEO were obtained by cloning their
coding sequences in sense orientation into the BamHI–XbaI site of
the mammalian expression vector pCDNA3, under the transcrip-
tional control of CMV promoter as recently described [16]. The
plasmid pCMV-TCII-OLEO (7.2 kb) codes for the protein TCII-
OLEO whereas pCMV-OLEO-TCII (7.1 kb) codes for the
protein OLEO-TCII. The plasmid pCMV-GFP-TCII-OLEO
(7.9 kb) encodes for the fusion protein green fluorescent protein
(GFP)-TCII-OLEO, which was used as reporter protein. The
control plasmids were pCMV-TCII (6.6 kb) coding for TCII, the
pCMV-OLEO (5.9 kb) coding for OLEO, and the empty plasmid
pCDNA3 (5.4 kb).
Transfection In Vitro
Neuroblastoma N1E-115 cells, used in stable expression assays,
were obtained from the American Type Culture Collection, and
cultured in DMEM supplemented with 10% fetal bovine serum (FBS)
and penicillin-streptomycin (100 mg/mL of each). Cell cultures were
kept at 37uCu n d e ra5 %C O 2 atmosphere. Transient and stable
transfections were preformed as described recently [16]. N1E-115
cells seeded in 6-well dishes were selected with 800 mg/mL of G418
(Sigma-Aldrich, St. Louis, MO, US) for 15 days, and then transferred
to 24-well dishes for viability studies. Stably selected N1E-115 cells
seeded on 12-mm microscope cover glasses were used for cleaved
Caspase-3 immunostaining and propidium iodide incorporation.
Synthesis of NTS-Vector and NTS-Polyplex Formation
Neurotensin (NTS)-polyplex is a non-viral system for the
targeted gene delivery to cells that express and internalize the
high-affinity NTS receptor (NTSR1) [41–44]. NTS-polyplex
results from the electrostatic binding of NTS-FP-poly-L-Lysine
(PLL) conjugate (the NTS-vector) with a plasmid DNA (pDNA)
previously bound with PK [45]. The detailed procedure of NTS-
vector synthesis was reported previously [42,43]. Briefly, NTS
(ELYENKPRRPYIL; Sigma, St. Louis, MO, USA) and FP
(GLFEAIAEFIEGGWEGLIEGCAKKK; purity .90%; SynPep,
Dublin, CA, USA) were cross-linked with PLL (48 kDa mean
molecular mass; Sigma, St. Louis, MO, USA) using LC-SPDP as
the cross-linker [42]. Suitable gel-filtration chromatography was
used to purify the SPDP derivatives and the NTS–FP–SPDP–PLL
conjugate (the NTS-vector). This conjugate was concentrated to
1 mL, further dialyzed against phosphate buffered saline solution
(PBS; 8.1 mM Na2HPO4, 1.2 mM KH2PO4, 138 mM NaCl,
2.7 mM KCl, pH 7.4), and sterilized by filtration.
The NTS-polyplexes were formed by electrostatically binding the
NTS-vector and the mutant Vp1 SV40 KP (MAPTKRKGSCP-
Figure 6. Methamphetamine-induced turning behavior in rats
transfected with several plasmids. The plasmids were pCMV-TCII-
OLEO coding for transcobalamin-oleosin (TO), pCMV-OLEO-TCII coding
for oleosin-transcobalamin (OT), pCMV-TCII coding for transcobalamin II
(T), pCMV-OLEO coding for oleosin (O), and pCDNA3 (P). The values are
the mean6SEM of 3 animals per group. **=Significantly different from
control groups. P,0.01, repeated-measures two-way ANOVA and
Bonferroni post-test.
doi:10.1371/journal.pone.0008268.g006
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different pDNAs at optimum molar ratio [44]. First, the KP was
electrostatically bound to pDNA to form the KP-pDNA complex.
The KP and the pDNA were dissolved in serum-free DMEM.
Similar amounts of 6 nM pDNA were incubated with increasing
amounts of KP (3, 6, 9, 12, 15, 18, 21, 24 mM) for 30 min at room
temperature and then subjected to 0.8% agarose gel electrophoresis
as described previously [44,45]. Since the KP concentration of
9 mMforpCMV-TCII-OLEOand6 mMforpCMV-OLEO-TCII,
pCMV-OLEO, pCMV-TCII and pCDNA3 do not saturate the
anionic charges of pDNA (6 nM), these concentrations were
selected to form the NTS-polyplex.
NTS-polyplexes were formed with a constant concentration of
KP-pDNA complexes and increasing concentrations of the NTS-
vector (18, 36, 54, 72, 90, 108, 126, 144, 162, 180, 198, 216,
234 nM). The reaction mixtures were incubated for 30 min at
room temperature and then subjected to 0.8% agarose gel
electrophoresis as described previously [44,45]. The concentra-
tions of NTS-vector producing the compete retention of KP-
pDNA complex in the gel well was considered as the optimum
molar ratio [44,45]. Those concentrations were 180 nM for
pCMV-TCII-OLEO and pCMV-OLEO-TCII, 162 nM for
pCMV-TCII and pCMV-OLEO, and 126 nM for pCDNA3.
The NTS-polyplex were injected 5X concentrated. The final
concentration of each component was: plasmid DNA, 30 nM for
all the constructs; KP, 45 mM for pCMV-TCII-OLEO and
30 mM for pCMV-OLEO-TCII, pCMV-OLEO, pCMV-TCII
and pCDNA; NTS-vector, 900 nM for pCMV-TCII-OLEO and
pCMV-OLEO-TCII, 810 nM for pCMV-TCII and pCMV-
OLEO, and 630 nM for pCDNA.
Transfections In Vivo
Adult male Wistar rats (weighing 210–230 gr at the onset of
experiment), bred in our facilities, were maintained under constant
room temperature (23uC), and light–dark cycle (12-12 h), with food
and water ad libitum. All procedures were in accordance with the
Mexican legislation (NOM-062-ZOO-1999; SAGARPA), based on
the Guide for the Care and Use of Laboratory Animals, NRC. The
CINVESTAV Committee for animal care and use (IACUC)
approved and supervised our experimental procedures (authoriza-
tion #0109-02). All efforts were made to minimize animal suffering.
Each rat was anesthetized by an intraperitoneal injection of chloral
hydrate (350 mg/kg) and placed in a stereotaxic instrument (Model
51600, Stoelting; Wood Dale, ILL, USA) with the incisor bar
5.5 mm below the interaural line. After cranial trepanation, 3 mLo f
the different NTS-polyplexes were unilaterally microinjected into
the dorsal border of left substantia nigra at the coordinates AP,
24.6 mm from bregma; ML, +1.5 mm from the interparietal
suture; DV, 26.8 mm from dura mater. The solution was injected
at a flow rate of 0.1 ml/min using a microsyringe (Hamilton
Company, Reno, Nevada, USA) and an automatic microperfusion
pump (Stoelting, Wood Dale, IL, USA). After surgery, all animals
were injected with monohydrate of Cefalexin (10 mg/kg, im) to
prevent infection [41,43,44].
Reverse Transcription-Polymerase Chain Reaction
Reverse transcription-polymerase chain reaction (RT-PCR) was
used to show mRNA expression in both stably transfected N1E-115
cells and rat substantia nigra. RNAs was extracted with Trizol
(Invitrogen Corporation Carlsbad, CA, USA) from 7610
5 N1E-115
cells or form a complete substantia nigra, quantified by spectropho-
tometry at 260 nm, and analyzed by 2%-agarose gel electrophoresis.
The RNA preparations were treated with RNase-free DNase before
their use in the reverse transcription. Five mg of total RNA was
transcribed with SuperScript II reverse transcriptase (200 U) using
0.1 mg of oligo dT (Invitrogen Corporation, Carlsbad, CA, USA).
One mL of the reverse transcribed product were amplified in a
temperature gene cycler (Gene Amp PCR System 9700; Applied
Biosystems, Foster city, CA, USA) using 1 nmol of each sense and
antisense primers and 1 U of Platinum Taq DNA polymerase
(Invitrogen Life Technologies, San Diego, CA, USA) in a final
volume of 50 mL. To amplify the components of the chimeric
proteins in transfected N1E-115 cells, we used Multiplex PCR along
with 2 pairs of specific oligonucleotides for TCII and OLEO. For
TCII, the forward primer was 59-CATTGGGCATGATCA-
CAAGGG-39, and the reverse primer was 59-G A G G A A T G G T C T -
CAGCAGCTGG-39 (GenBank access: NM_000355). For OLEO,
the forward primer was 59- TCACTTCTCGGAACCATAAT -39,
and the reverse primer was 59- CCAGCATCCTTTGTCTT-
CTGCC-39 (GenBank access: AY605694). In cells transfected with
TCII the amplified fragment was of 551 bp, whereas the fragment
was 275 bp in cell transfected with OLEO. In cells transfected with
the chimeric proteins, the amplified fragments were 1347 bp for
TCII-OLEO and 1240 bp for OLEO-TCII, which include the two
components of the chimeric proteins. The internal control was a
349-bp-product of b-actin amplified using the forward primer 59-
CGTAAAGACCTCTATGCCAA-39 and the reverse primer 59-
AGCCATGCCAAATGTCTCAT-39. Afteran initial denaturation
at 94uC for 2 min, amplification was done with 30 cycles as follows:
denaturation, 94uC for 1 min; annealing, 59uC for multiplex PCR
or 56uC for b-Actin; extension, 72uC for 1 min. Conventional PCR
was used to amplify TCII-OLEO and OLEO-TCII products in the
substantianigra.Toamplifya380 bpfragmentofTCII-OLEO,the
forward primer was 59-TTAGTCTCTTGCCGCCGTACAG-39,
and the reverse primer was 59-ACCACCACTAACATCG-
TAGCCG-39. To amplify a 394 bp fragment of OLEO-TCII the
forward primer was 59-TCACTTCTCGGAACCATAATCGG-39
and the reverse primer was 59-CCATCCAAGGTAAGAGG-
TGCTG-39. After an initial denaturation at 94uC for 2 min,
amplificationwasdonewith30cyclesasfollows:denaturation,94uC
for 1 min, annealing, 58uC for TCII-OLEO or 57uC for OLEO-
TCII; extension, 72uC for 1 min. b-actin was used as internal
control using the primers and PCR conditions described above.
PCR products were analyzed by 2% agarose gel electrophoresis,
stained with ethidium bromide, and photographed with a Kodak
DC290 camera.
Cell Viability
After transfection, N1E-115 cells seeded in 6-well dishes were
selected with 800 mg/mL of G418 (Sigma-Aldrich, St. Louis, MO,
US) for 15 days, and then transferred to 24-well dishes for viability
studies. Cell viability was monitored using the colorimetric MTT
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide)
assay to explore whether the protein expression could produce
cytotoxicity in stably transfected N1E-115 cells. Briefly, after a 15-
day selection period with G418, 6000 N1E-115 cells were seeded
in 24-well plates and incubated with MTT (Roche Diagnostics
Corporation; Indianapolis, IN, USA) at a final concentration of
0.5 mg/mL of incubation medium, for 4 h. Then, the solubiliza-
tion solution (10% SDS, 0.01 M HCl) was added into the wells
and incubated overnight. The total volume of each well was
transferred to respective wells of an ELISA plate to determine the
absorbance at 595/690 nm using a multiwell microtiter plate
reader (Labsystems Multiskan, Multisoft, Helsinki, Finland).
Western Blot
Proteins were extracted from the cell homogenates with Trizol
following the manufacturer’s protocol. Fifty micrograms of proteins
Vitamin B12 and Parkinson
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Rockford, IL, USA) were subjected to electrophoresis in 10% SDS–
PAGE gels and transferred onto nitrocellulose membranes (Amer-
sham Bio-Sciences, Piscataway, NJ, USA). After blocking in 5% skim
milk in 50 ml phosphate buffered saline solution (PBS; 8.1 mM
Na2HPO4,1 . 2 m MK H 2PO4, 138 mM NaCl, 2.7 mM KCl,
pH 7.4) – 0.1% Tween 20 for 1 h with shaking, membranes were
incubated with either a goat polyclonal antibody to TCII (1:8000
dilution; Santa Cruz Biotechnology, Santa Cruz, CA, USA), a rabbit
cleaved Caspase-3 (1:600; Cell Signaling Technology Inc., Danvers,
MA), a mouse anti-p53 peroxidase-labeled antibody (1:500 dilution;
Santa Cruz Biotechnology) at 4uC overnight. Secondary antibodies
(incubation 2 h at room temperature) were a peroxidase-labeled
donkey anti-goat IgG (1:20000 dilution; Zymed, San Francisco, CA,
USA) and a peroxidase-labeled donkey anti-rabbit IgG (1:10000
dilution; Amersham Bio-Sciences, Piscataway, NJ, USA). A Super-
signal West pico chemiluminescence kit (Pierce Biotechnology,
Rockford, IL, USA) and Kodak Biomax MR films were used for
detection of the immunoreactivity. To normalize the total amount of
protein per lane, membranes were stripped and incubated with a
monoclonal mouse antibody against actin (1:500 dilution; (CINVES-
TAV, Mexico)) and the peroxide-labeled goat anti-mouse IgG
(1:10000 dilution; Zymed, San Francisco, CA, USA). The immuno-
reactivity was detected by chemiluminescence.
Immunofluorescence Assays
Using indirect immunofluorescence of TCII showed transgenic
expression, whereas apoptosis was shown by indirect immunofluo-
rescence of cleaved Caspase-3. Apoptosis and necrosis were explored
in stably transfected N1E-115 cells at the 6th day in culture. The
latter cells were incubated with 4 mM propidium iodide added in the
culture medium to mark necrotic cells and 10 min later were fixed
and immunostained against cleaved Caspase-3 to determine
apoptosis. TCII and TH double immunofluorescence was used to
show the transgenic expression in dopamine neurons. Cultured cells
were washed once with PBS and fixed with 4% paraformaldehyde.
Rats were deeply anesthetized with chloral hydrate and trans-
cardially perfused through the ascending aorta with 100 ml of PBS,
followed by 100 mL of 4% paraformaldehyde in PBS. The brains
were dissected out and immersed in 4% paraformaldehyde at 4uCf o r
24 h. After an additional incubation in PBS containing 30% of
sucrose at 4uC for 72 h, brains were frozen and sectioned into 40 mm
slices on the coronal or sagital plane using the Leica CM1100 cryostat
(Leica Microsystems; Nussloch, Germany). Permeabilization was
made with 0.1% Triton X-100 in PBS for 30 min for cultured cells
and 60 min for tissue sections, at room temperature (RT). After
blocking the nonspecific binding sites with horse serum (5% for
cultured cells and 10% for tissue sections) dissolved in PBS–0.1%
Triton X-100 for 30 min at room temperature (RT), the cells were
incubated with the primary antibody over night at 4uC. The primary
antibodies were, a goat polyclonal antibody anti-TCII (1:50 dilution;
Santa Cruz Biotechnology, Santa Cruz, CA, USA), a mouse
monoclonal antibody anti-human golgin-97 (1:50 dilution; Molecular
Probes Inc, Eugene, OR, USA), a rabbit polyclonal antibody anti-
calreticulin (1:100 dilution; Bioreagents, Golden, CO, USA), and a
rabbit polyclonal cleaved anti-caspase-3 (1:500 dilution; New
England Biolabs, Beverly, MA, USA). After washing with PBS, cells
and slides were incubated for 2 h at RT with the suitable secondary
antibody. These antibodies were, a FITC-donkey anti-goat IgG (1:60
dilution; Jackson ImmunoResearch; Palo Alto, CA, USA Palo Alto,
C A ,U S A ) ,aF I T C -( 1 : 6 0S i g m a ,S t .L o u i s ,M O ,U S A )o rR h o -
donkey anti-rabbit IgG (1:60 Jackson ImmunoResearch; Palo Alto,
CA, USA), and Rho- or AMCA-donkey anti-mouse IgG (1:60
JacksonImmunoResearch;PaloAlto,CA,USA),incubatedfor2 hat
RT. Finally, the cells and slices were washed and mounted on glass
slides using Vectashield (Vector Laboratories, Burlingame, CA,
USA). The fluorescence was observed with a Leica DMIRE2
microscope using the objectives 5X, 20X, and 40X, and the filters A
for AMCA or Hoechst 33258, K3 for FITC, and TX2 for Rho. The
images were digitized with a Leica DC300F camera (Nussloch,
Germany). Negative controls were obtained by omitting the primary
antibody, and replacing it by an irrelevant antibody of the same IgG
subclass. Fluorescence labeling was also viewed through a multispec-
tral confocal laser-scanning microscope (TCS-SPE, Leica, Heidel-
berg) using a 60X oil-immersion objective at excitation-emission
wavelengths of 405–465 nm (blue channel), 488–522 nm (green
channel), and 568–635 nm (red channel). Twenty to forty consec-
utive optical sections at 0.3-mm intervals were obtained in the z-series.
The resulting images were projected on a bidimensional plane and
were overlapped onthe screen monitor using blue for Hoechst33258,
green for GFP and FITC, and red for TRITC.
Behavioral Testing
Ipsilateral turning behavior caused by intraperitoneal injection of
methamphetamine (8 mg/kg of body weight) was automatically
assessed at 30 and 60 days after transfection by using a homemade
device [23]. Rats were fitted around the chest with a Velcro harness
connected to a flexible cable and placed in a cylindrical plastic
container measuring 30 cm in diameter and 40 cm high. The cables
were attached to a light bi-directional swivel switcher interfaced with
a microcomputer. Number and direction of turns were evaluated
automatically with the following algorithms: left direction, 0,1
interruptions; right direction, 1,0 interruptions; and turn counter,
1,1 interruptions. The rotational asymmetry score was expressed as
full body turns per minute over a 90 min period. The open field test
was performed as described [45].
Statistical Analysis
All values are expressed as the mean6SEM. The repeated-
measures two-way ANOVA was used to analyze the difference in cell
viability and turning behaviors. The difference between pairs of
means was shown by the Bonferroni post-test. The statistical analysis
was done with the Graph Pad Software (San Diego, CA, USA). In all
analyses, the null hypothesis was rejected at the 0.05 level.
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